Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2024-05-03 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
240503 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Acquisition of own shares' and explicitly details the repurchase of UCB shares on Euronext Brussels between April 29, 2024, and May 02, 2024, under the 'Share Repurchase Program 2024'. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is Transaction in Own Shares (POS). The document length is short (2625 chars), but it is a detailed disclosure of the transaction itself, not merely an announcement that a report is available, making POS more specific than RPA or RNS.
2024-05-03 English
240503 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres" (Share Buyback) and explicitly states it is providing information regarding the company's 2024 Share Buyback Program, detailing the number of shares repurchased between April 29, 2024, and May 2, 2024. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers the company buying back or selling its own shares (share repurchase/issuance). The document length is short (2746 chars) and it is a direct announcement of the transaction details, not an announcement of a future report.
2024-05-03 French
240503 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving van eigen aandelen" (Acquisition of own shares) and explicitly details the number of shares repurchased by UCB NV on Euronext Brussels between April 29, 2024, and May 2, 2024, including transaction dates, quantities, and prices. This directly corresponds to the definition of a 'Transaction in Own Shares' (share repurchase). The document is short (2750 characters) and functions as a regulatory disclosure of this specific activity, fitting the 'POS' code perfectly. It is not a general earnings release (ER), a full annual report (10-K), or just an announcement of a report (RPA), but a specific report on share transactions.
2024-05-03 Dutch
240426 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly discusses the 'Acquisition of own shares' and details the number of shares repurchased by UCB SA/NV on Euronext Brussels between specific dates (April 19 to April 26, 2024) under its Share Repurchase Program 2024. This activity directly corresponds to the definition of a company buying back its own shares. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification.
2024-04-26 English
240426 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Rachat d'actions propres' (Share Buyback) and is dated April 26, 2024. It explicitly details the number of shares repurchased (15,994) during a specific period (April 19 to April 26, 2024) under the 2024 Share Buyback Program. This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase reports. The document is a direct report of the transaction, not an announcement of a report, and its length (2545 chars) is consistent with a specific regulatory disclosure rather than a general announcement.
2024-04-26 French
240426 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving van eigen aandelen" (Acquisition of own shares) and explicitly details the number of shares repurchased by UCB NV on Euronext Brussels between April 19, 2024, and April 26, 2024, under the Aandelen Inkoopprogramma 2024 (Share Buyback Program 2024). This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is Transaction in Own Shares (POS). The document length is short (2527 chars), but it is a direct report of the transaction, not an announcement of a report's publication.
2024-04-26 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.